Q9NR97 (TLR8_HUMAN) Homo sapiens (Human)

Toll-like receptor 8 UniProtKBInterProInteractive Modelling

1041 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human TLR8 in complex with CU-CPD107
7crf
homo-2-mer32-827
1×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 2×GD0; 21×NAG;
Assess
Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity
6zjz
homo-2-mer30-822
2×NAG; 2×NAG; 2×NAG; 9×NAG; 2×QLH; 1×FMT;
Assess
Crystal structure of TLR8 in complex with its antagonist
7ytx
homo-2-mer32-821
1×NAG; 2×NAG; 2×NAG; 1×NAG; 2×JRI; 18×NAG;
Assess
Crystal structure of human TLR8 in complex with XG-1-236
4qc0
homo-2-mer31-819
3×NAG; 1×NAG; 5×NAG; 2×XG1;
Assess
Crystal structure of human TLR8 in complex with DS-802
4qbz
homo-2-mer31-818
1×NAG; 2×NAG; 2×NAG; 1×NAG; 11×NAG; 2×D80;
Assess
Crystal structure of human TLR8 in complex with N1-4-aminomethylbenzyl (IMDQ)
5awd
homo-2-mer31-818
2×NAG; 2×NAG; 2×NAG; 2×IDQ; 14×NAG;
Assess
Crystal structure of human TLR8 in complex with Hybrid-2
4r6a
homo-2-mer31-818
2×NAG; 4×NAG; 10×NAG; 2×HB2;
Assess
Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 3
3w3n
homo-2-mer31-818
4×NAG; 2×NAG; 13×NAG; 2×RX8; 1×GOL;
Assess
Crystal structure of human TLR8 (unliganded form)
3w3g
homo-2-mer32-819
5×NAG; 1×NAG; 10×NAG; 1×BU3;
Assess
Crystal structure of human TLR8 in complex with CL075
3w3k
homo-2-mer31-818
4×NAG; 1×NAG; 1×NAG; 2×L07; 6×NAG;
Assess
Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 1
3w3l
homo-2-mer31-818
4×NAG; 2×NAG; 8×NAG; 4×SO4; 2×RX8;
Assess
Crystal structure of human TLR8 in complex with CU-CPT8m
5wyx
homo-2-mer32-819
3×NAG; 2×NAG; 1×NAG; 6×NAG; 2×CU8;
Assess
Crystal structure of human TLR8 in complex with MB-343
5az5
homo-2-mer31-818
3×NAG; 2×NAG; 1×NAG; 2×MBL; 7×NAG;
Assess
Crystal structure of human TLR8 in complex with MB-564
5awc
homo-2-mer31-818
4×NAG; 2×NAG; 5×NAG; 2×M4D;
Assess
Human TLR8 bound to the potent agonist, GS-9688 (Selgantolimod)
6wml
homo-2-mer31-818
1×NAG; 1×NAG; 4×NAG; 6×MAN; 9×NAG; 2×U57;
Assess
Crystal structure of human TLR8 in complex with ORN06S
4r09
homo-2-mer32-819
1×NAG; 4×NAG; 1×NAG; 2×URI; 2×06S; 2×UPT; 2×NAG;
Assess
Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 2
3w3m
homo-2-mer31-818
4×NAG; 2×NAG; 2×RX8; 8×NAG; 2×SO4;
Assess
Crystal structure of human TLR8 in complex with compound 34
8pfi
homo-2-mer31-818
4×NAG; 2×NAG; 12×NAG; 2×YHG;
Assess
Crystal structure of human TLR8 in complex with Compound 4
7r54
homo-2-mer31-818
4×NAG; 2×NAG; 12×NAG; 2×I5B;
Assess
Crystal structure of human TLR8 in complex with Compound 2
7r52
homo-2-mer31-818
4×NAG; 2×NAG; 12×NAG; 2×I6A;
Assess
Crystal structure of human TLR8 in complex with Compound 15
7r53
homo-2-mer31-818
4×NAG; 2×NAG; 12×NAG; 2×I5N;
Assess
Crystal structure of human TLR8 in complex with DS-877
3wn4
homo-2-mer32-818
2×NAG; 4×NAG; 2×D87; 18×NAG;
Assess
Crystal structure of human TLR8 in complex with CL097
3w3j
homo-2-mer31-817
2×NAG; 2×NAG; 2×NAG; 8×NAG; 2×C09; 16×SO4; 1×GOL;
Assess
Crystal structure of human TLR8 in complex with ORN06
4r07
homo-2-mer32-818
1×NAG; 3×NAG; 2×NAG; 2×URI; 2×UCG; 10×NAG;
Assess
Crystal structure of human TLR8 in complex with N1-3-aminomethylbenzyl (meta-amine)
5awb
homo-2-mer31-817
2×NAG; 2×NAG; 2×NAG; 2×M0A; 6×NAG;
Assess
Crystal structure of human TLR8 in complex with CU-CPT9b
5wyz
homo-2-mer32-818
3×NAG; 2×NAG; 1×NAG; 2×7VF; 4×NAG;
Assess
Crystal structure of human TLR8 in complex with ssRNA40
4r08
homo-2-mer32-818
4×NAG; 2×NAG; 2×URI; 10×NAG; 2×UCG;
Assess
Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 14c
6v9u
homo-2-mer32-818
4×NAG; 1×NAG; 1×NAG; 17×NAG; 2×QSM;
Assess
Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 21
7rc9
homo-2-mer32-818
2×NAG; 3×NAG; 1×NAG; 14×NAG; 2×RQY;
Assess
Crystal structure of human TLR8 in complex with CU-CPT9a
5z14
homo-2-mer32-818
1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 2×7VC; 3×NAG;
Assess
Crystal structure of human TLR8 in complex TH1027
6kya
homo-2-mer32-818
2×NAG; 2×NAG; 2×NAG; 2×DY3; 8×NAG;
Assess
Crystal structure of human TLR8 in complex with CU-CPT9c
5z15
homo-2-mer32-818
3×NAG; 2×NAG; 1×NAG; 2×7VL; 1×MAN; 4×NAG;
Assess
Crystal structure of human TLR8 in complex with uridine mononucleoside
4r0a
homo-2-mer32-817
2×NAG; 2×NAG; 2×NAG; 2×URI; 14×NAG;
Assess
Crystal structure of human TLR8 in complex with MB-568
5awa
homo-2-mer32-816
2×NAG; 2×NAG; 2×NAG; 2×M8D; 12×NAG;
Assess
Crystal structure of human TLR8 with an uncleaved Z-loop
5hdh
monomer33-823
1×NAG; 1×NAG; 1×NAG; 6×NAG; 3×SO4; 1×MES;
Assess
Crystal structure of human TLR8 in complex with Compound 11
6ty5
monomer31-818
2×NAG; 1×NAG; 6×NAG;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8pfi.1.Ahomo-2-mer0.7931-818
2×NAG; 2×NAG; 7×NAG; 1×YHG;100.00
Assess
7cyn.1.Amonomer0.7041-853
42.97
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27r54.1.Ahomo-2-mer0.7849-836
3×NAG; 9×NAG;100.00
Assess
Isoform 27cyn.1.Amonomer0.7060-871
43.02
Assess
Isoform 27wv3.1.Ahomo-4-mer0.5261-840
26.20
Assess
Isoform 23cig.1.Amonomer0.5062-841
24.19
Assess